Non-invasive assessment of endothelial dysfunction: A novel method to predict severe COVID-19?

Area of Science:

• Cardiovascular Medicine
• Infectious Diseases
• Biomedical Engineering

Background:

• The COVID-19 pandemic, caused by SARS-CoV-2, has led to significant global health challenges and strained healthcare systems.
• Endothelial dysfunction, a known complication of SARS-CoV-2 infection, is increasingly recognized as a key factor in COVID-19's high morbidity and mortality rates.
• Early identification of patients likely to develop severe COVID-19 complications is crucial for effective management and resource allocation.

Purpose of the Study:

• To review the potential of assessing endothelial dysfunction as a prognostic parameter for COVID-19 patients.
• To explore how emerging non-invasive technologies for measuring endothelial dysfunction can aid in predicting cardiovascular risk in COVID-19.
• To discuss the implications of this technology for patient prognostication and clinical management strategies.

Main Methods:

• Review of current literature on COVID-19, endothelial dysfunction, and cardiovascular risk assessment.
• Examination of emerging non-invasive technologies for measuring endothelial function.
• Analysis of the potential application of these technologies in the context of COVID-19 patient management.

Main Results:

• Endothelial dysfunction is a significant contributor to severe outcomes in COVID-19.
• Non-invasive assessment of endothelial dysfunction shows promise in predicting cardiovascular risk.
• This technology offers a potential tool for early prognostication in COVID-19 patients.

Conclusions:

• Assessing endothelial dysfunction via emerging non-invasive technologies presents a valuable strategy for COVID-19 patient prognostication.
• This approach can aid clinicians in identifying high-risk individuals, facilitating timely interventions.
• Implementing such assessments may help optimize patient management and alleviate healthcare system burdens.